Sept 18 (Reuters) - Ascelia Pharma AB ACELP.ST :
* FIRST COMMERCIAL SCALE MANUFACTURING OF MANGORAL
* REACHED A KEY ACHIEVEMENT WITH FIRST COMMERCIAL SCALE
MANUFACTURING OF ITS LEAD COMPOUND MANGORAL, CURRENTLY IN
PIVOTAL PHASE 3 DEVELOPMENT
* FIRST AND REPRODUCEABLE COMMERCIAL SCALE MANUFACTURING IS
AN
IMPORTANT STEP TOWARDS A PRODUCT APPROVAL AND LAUNCH, WHICH WE
EXPECT IN LATE 2022 OR BEGINNING OF 2023
Source text for Eikon: ID:nWkr7SZQnd
Further company coverage: ACELP.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))